600518.SS
600518.SS
CNE0000017M1
KANGMEI PHARMACEUTICAL CO LTD
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 5.252.215.058 5.189.137.200
1.2%
Cost of Revenue 4.203.085.987 4.422.148.258
5.0%
Gross Profit 1.049.129.071 766.988.942
36.8%
937.446.315 741.374.880
26.4%
Operating Income 111.682.756 25.614.062
336.0%
Pretax Income 43.115.914 34.650.440
24.4%
Net Income Common Stockholders 10.327.998 8.573.663
20.5%
-- --
--
-- --
--
ende